Clinical trial
A Randomized, Double-blind Clinical Trial of Anticoagulation Therapy With Warfarin in Caribbean Hispanics: Comparison Between an Admixture-adjusted Pharmacogenetic-driven Warfarin Dose Refinement Algorithm and the Standard of Care
NCT02345356 is registered in ClinicalTrials.gov with University of Puerto Rico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind Clinical Trial of Anticoagulation Therapy With Warfarin in Caribbean Hispanics: Comparison Between an Admixture-adjusted Pharmacogenetic-driven Warfarin Dose Refinement Algorithm and the Standard of Care
- Lead sponsor
- University of Puerto Rico
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- May 17, 2022
- Enrollment
- 200 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, cardiac valvular insufficiency, coagulopathies, deep vein thrombosis, pulmonary embolism